Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JD.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.25ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.25NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.79ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.79ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.79ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.79NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HP.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HP.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FU.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FU.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FU.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EY.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EY.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.35ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.35NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.18ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.18NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EL.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EL.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.44ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.44ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.44NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FU.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FU.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FU.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used